AT370129B - Verfahren zur herstellung einer neuen biologisch aktiven substanz - Google Patents

Verfahren zur herstellung einer neuen biologisch aktiven substanz

Info

Publication number
AT370129B
AT370129B AT0205480A AT205480A AT370129B AT 370129 B AT370129 B AT 370129B AT 0205480 A AT0205480 A AT 0205480A AT 205480 A AT205480 A AT 205480A AT 370129 B AT370129 B AT 370129B
Authority
AT
Austria
Prior art keywords
producing
active substance
biologically active
new biologically
new
Prior art date
Application number
AT0205480A
Other languages
English (en)
Other versions
ATA205480A (de
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of ATA205480A publication Critical patent/ATA205480A/de
Application granted granted Critical
Publication of AT370129B publication Critical patent/AT370129B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/265—Micrococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/859—Micrococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT0205480A 1979-04-18 1980-04-16 Verfahren zur herstellung einer neuen biologisch aktiven substanz AT370129B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7909743A FR2454302A1 (fr) 1979-04-18 1979-04-18 Nouvelle substance biologiquement active, sa preparation et les medicaments qui la contiennent

Publications (2)

Publication Number Publication Date
ATA205480A ATA205480A (de) 1982-07-15
AT370129B true AT370129B (de) 1983-03-10

Family

ID=9224428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0205480A AT370129B (de) 1979-04-18 1980-04-16 Verfahren zur herstellung einer neuen biologisch aktiven substanz

Country Status (26)

Country Link
US (1) US4313936A (de)
JP (1) JPS5611795A (de)
AT (1) AT370129B (de)
AU (1) AU538492B2 (de)
BE (1) BE882841A (de)
CA (1) CA1122526A (de)
CH (1) CH646873A5 (de)
DE (1) DE3015030A1 (de)
DK (1) DK163980A (de)
ES (1) ES8200920A1 (de)
FI (1) FI67571C (de)
FR (1) FR2454302A1 (de)
GB (1) GB2046759B (de)
GR (1) GR66676B (de)
HU (1) HU181104B (de)
IE (1) IE49446B1 (de)
IL (1) IL59842A (de)
IT (1) IT1209323B (de)
LU (1) LU82370A1 (de)
NL (1) NL8002108A (de)
NO (1) NO155103C (de)
NZ (1) NZ193457A (de)
PT (1) PT71107A (de)
SE (1) SE446344B (de)
SU (1) SU1042602A3 (de)
ZA (1) ZA802271B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2522945B2 (ja) * 1987-06-18 1996-08-07 呉羽化学工業株式会社 抗レトロウィルス剤
CH680192A5 (de) * 1989-12-13 1992-07-15 Nestle Sa
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547388A (fr) * 1967-02-22 1968-11-29 Rhone Poulenc Sa Nouvel antibiotique et sa préparation par culture d'un streptomyces
US4174390A (en) * 1977-02-07 1979-11-13 Eli Lilly And Company Antibiotic A-7413 and process for preparation thereof
US4180565A (en) * 1978-05-25 1979-12-25 Schering Corporation 1-N-substituted derivatives of 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols

Also Published As

Publication number Publication date
DE3015030C2 (de) 1988-09-08
ES490702A0 (es) 1981-11-16
AU538492B2 (en) 1984-08-16
ATA205480A (de) 1982-07-15
US4313936A (en) 1982-02-02
DE3015030A1 (de) 1981-05-07
ZA802271B (en) 1981-04-29
NL8002108A (nl) 1980-10-21
NO801114L (no) 1980-10-20
AU5749480A (en) 1980-10-23
CH646873A5 (fr) 1984-12-28
SE446344B (sv) 1986-09-01
CA1122526A (fr) 1982-04-27
IT8021495A0 (it) 1980-04-18
FI67571C (fi) 1985-04-10
JPS5611795A (en) 1981-02-05
SE8002898L (sv) 1980-10-19
NZ193457A (en) 1983-02-15
HU181104B (en) 1983-06-28
IE49446B1 (en) 1985-10-02
IE800772L (en) 1980-10-18
IL59842A0 (en) 1980-06-30
SU1042602A3 (ru) 1983-09-15
ES8200920A1 (es) 1981-11-16
LU82370A1 (fr) 1980-12-16
DK163980A (da) 1980-10-19
GB2046759A (en) 1980-11-19
NO155103C (no) 1987-02-11
IT1209323B (it) 1989-07-16
FI67571B (fi) 1984-12-31
FR2454302B1 (de) 1982-05-21
BE882841A (fr) 1980-10-17
NO155103B (no) 1986-11-03
GR66676B (de) 1981-04-08
FR2454302A1 (fr) 1980-11-14
PT71107A (fr) 1980-05-01
JPS6251275B2 (de) 1987-10-29
GB2046759B (en) 1983-02-23
IL59842A (en) 1984-02-29
FI801251A (fi) 1980-10-19

Similar Documents

Publication Publication Date Title
AT379390B (de) Verfahren zur herstellung von neuen chinolonverbindungen
AT380259B (de) Verfahren zur herstellung von neuen peptidamiden
AT368509B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporinen
ATA427680A (de) Verfahren zur herstellung von neuen 6-pyridazinonen
AT371816B (de) Verfahren zur herstellung von neuen isocyanurs[urederivaten
AT371146B (de) Verfahren zur herstellung einer neuen antibiotischen substanz
AT370129B (de) Verfahren zur herstellung einer neuen biologisch aktiven substanz
AT364082B (de) Verfahren zur herstellung der neuen antibiotischen substanz mycoplanecin
ATA232880A (de) Verfahren zur herstellung von neuen steroidverbindungen
AT368516B (de) Verfahren zur herstellung von neuen nitrosoharnstoff-verbindungen
AT357669B (de) Verfahren zur herstellung einer neuen anti- biotischen substanz
AT368511B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT373595B (de) Verfahren zur herstellung von neuen chinazolinen
AT381722B (de) Verfahren zur herstellung einer neuen carcinostatischen substanz
ATA655779A (de) Verfahren zur herstellung eines neuen baustoffes
AT368517B (de) Verfahren zur herstellung von neuen nitrosoharnstoffverbindungen
AT352271B (de) Verfahren zur herstellung einer neuen antibiotischen substanz
AT373598B (de) Verfahren zur herstellung einer neuen oxathiaverbindung und ihrer salze
AT372947B (de) Verfahren zur herstellung von neuen trans-6oxodecahydrochinolinen
AT383122B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
ATA376683A (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
ATA185084A (de) Verfahren zur herstellung von neuen chinolonverbindungen
AT371114B (de) Verfahren zur herstellung von neuen phenyliminothiadiazolinen
AT368162B (de) Verfahren zur herstellung von neuen 7alphamethyoxycephalosporinen
AT368163B (de) Verfahren zur herstellung von neuen 7alphamethoxycephalosporinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification